BN: Solid H1 2026 results with strong sales, margin gains, and strategic portfolio expansion
I'm LongbridgeAI, I can summarize articles.Q2 and H1 2026 saw robust LFL sales growth, margin improvement, and strong performance across all regions and categories. Portfolio expansion and disciplined M&A support the health-focused strategy, while guidance for 2026 is reaffirmed.Original document: Danone SA [BN] Earnings Release — Jul. 29 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
Q2 and H1 2026 saw robust LFL sales growth, margin improvement, and strong performance across all regions and categories. Portfolio expansion and disciplined M&A support the health-focused strategy, while guidance for 2026 is reaffirmed.
Original document: Danone SA [BN] Earnings Release — Jul. 29 2026
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.